Telomir Pharmaceuticals, Inc. (TELO)

Last Closing Price: 0.42 (2026-11-18)

Shareholders Equity (Quarterly)

Shareholders Equity: The sum of preferred and common equity items.

Telomir Pharmaceuticals, Inc. (TELO) had Shareholders Equity of $4.40M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-0.71M
--
--
$0.75M
$-0.75M
$0.04M
$-0.71M
$-0.71M
$-0.71M
$-0.71M
$-0.71M
$-0.71M
$-0.75M
$-0.75M
68.78M
68.78M
$-0.01
$-0.01
Balance Sheet Financials
$4.64M
--
--
$4.64M
$0.24M
--
--
$0.24M
$4.40M
$4.40M
Shareholders Equity
$4.40M
68.78M
Cash Flow Statement Financials
$-3.37M
--
$0.60M
$7.29M
$4.52M
$-2.77M
$0.90M
--
--
Fundamental Metrics & Ratios
19.60
--
--
--
0.02
--
--
--
--
--
--
$-3.37M
--
--
--
--
--
--
--
-16.01%
-16.01%
-15.19%
-16.01%
$0.06
$-0.05
$-0.05